2021 Q4 Form 10-Q Financial Statement

#000165495421011834 Filed on November 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $209.0K $207.0K $226.0K
YoY Change -8.33% -8.41% -29.15%
% of Gross Profit
Research & Development $372.0K $442.0K $112.0K
YoY Change 294.64% -86.26%
% of Gross Profit
Depreciation & Amortization $7.000K $8.000K $6.000K
YoY Change 16.67% 33.33% 0.0%
% of Gross Profit
Operating Expenses $588.0K $674.0K $344.0K
YoY Change 55.56% 95.93% -69.82%
Operating Profit
YoY Change
Interest Expense $220.0K -$27.00K $291.0K
YoY Change -204.76% -109.28% -185.59%
% of Operating Profit
Other Income/Expense, Net -$102.0K -$27.00K $291.0K
YoY Change -270.0% -109.28%
Pretax Income -$470.0K -$701.0K -$53.00K
YoY Change -11.99% 1222.64% -96.42%
Income Tax
% Of Pretax Income
Net Earnings -$470.0K -$701.0K -$53.00K
YoY Change -11.99% 1222.64% -96.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$7.872K -$11.99K -$912.10
COMMON SHARES
Basic Shares Outstanding 58.94M shares 58.44M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $463.3K $1.780M $8.574M
YoY Change -79.18% -79.24% -1.07%
Cash & Equivalents $462.0K $554.0K $413.0K
Short-Term Investments $1.307K $1.226M $8.161M
Other Short-Term Assets $303.0K $3.283M $28.00K
YoY Change 1065.38% 11625.0% -91.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.159M $6.048M $8.602M
YoY Change -11.06% -29.69% -4.33%
LONG-TERM ASSETS
Property, Plant & Equipment $16.45M $16.29M $15.70M
YoY Change 4.8% 3.74% -0.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $154.0K $174.0K $74.00K
YoY Change 24.19% 135.14% 138.71%
Total Long-Term Assets $16.46M $16.30M $15.78M
YoY Change 4.49% 3.33% -0.11%
TOTAL ASSETS
Total Short-Term Assets $7.159M $6.048M $8.602M
Total Long-Term Assets $16.46M $16.30M $15.78M
Total Assets $23.62M $22.35M $24.38M
YoY Change -0.76% -8.32% -1.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $239.0K $215.0K $141.0K
YoY Change 52.23% 52.48% -25.0%
Accrued Expenses $37.00K $36.00K $17.00K
YoY Change 428.57% 111.76% -57.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $70.00K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $276.0K $251.0K $247.0K
YoY Change 58.62% 1.62% 6.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $160.0K $171.0K $125.0K
YoY Change 28.0% 36.8% -11.97%
Total Long-Term Liabilities $160.0K $171.0K $125.0K
YoY Change 28.0% 36.8% -11.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $276.0K $251.0K $247.0K
Total Long-Term Liabilities $160.0K $171.0K $125.0K
Total Liabilities $436.0K $422.0K $372.0K
YoY Change 45.82% 13.44% -0.53%
SHAREHOLDERS EQUITY
Retained Earnings -$49.96M -$49.49M
YoY Change 4.97%
Common Stock $620.0K $586.0K
YoY Change 6.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.18M $21.93M $24.01M
YoY Change
Total Liabilities & Shareholders Equity $23.62M $22.35M $24.38M
YoY Change -0.76% -8.32% -1.64%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$470.0K -$701.0K -$53.00K
YoY Change -11.99% 1222.64% -96.42%
Depreciation, Depletion And Amortization $7.000K $8.000K $6.000K
YoY Change 16.67% 33.33% 0.0%
Cash From Operating Activities -$434.0K -$993.0K -$195.0K
YoY Change 47.62% 409.23% -85.97%
INVESTING ACTIVITIES
Capital Expenditures -$177.0K -$257.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.185M $1.360M $238.0K
YoY Change -343.83% 471.43% -79.62%
Cash From Investing Activities -$1.362M $1.103M $238.0K
YoY Change -380.25% 363.45% -79.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.704M 39.00K -1.000K
YoY Change -4000.0% 0.0%
NET CHANGE
Cash From Operating Activities -434.0K -993.0K -195.0K
Cash From Investing Activities -1.362M 1.103M 238.0K
Cash From Financing Activities 1.704M 39.00K -1.000K
Net Change In Cash -92.00K 149.0K 42.00K
YoY Change -147.92% 254.76% -118.34%
FREE CASH FLOW
Cash From Operating Activities -$434.0K -$993.0K -$195.0K
Capital Expenditures -$177.0K -$257.0K
Free Cash Flow -$257.0K -$736.0K
YoY Change -12.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 sir Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
25000 USD
sir Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
-70000 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58936399 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
174000 USD
CY2021Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 USD
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
605000 USD
CY2021Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
3884000 USD
CY2020Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
5798000 USD
CY2021Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1226000 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1620000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
384000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
6048000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8049000 USD
CY2021Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
16129000 USD
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
15628000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 USD
CY2021Q3 us-gaap Assets
Assets
22351000 USD
CY2020Q4 us-gaap Assets
Assets
23801000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
215000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
157000 USD
CY2021Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
0 USD
CY2020Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
10000 USD
CY2021Q3 sir Operating Lease Liabilitycurrent
OperatingLeaseLiabilitycurrent
36000 USD
CY2020Q4 sir Operating Lease Liabilitycurrent
OperatingLeaseLiabilitycurrent
7000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
251000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
171000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
125000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58633766 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58108366 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
586000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
581000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70833000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70514000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49490000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47593000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
21929000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23502000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22351000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23801000 USD
CY2021Q3 sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
442000 USD
CY2020Q3 sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
112000 USD
sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
826000 USD
sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
269000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
207000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
226000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
743000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
816000 USD
CY2021Q3 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
17000 USD
CY2020Q3 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 USD
us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
17000 USD
us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
674000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
344000 USD
us-gaap Operating Expenses
OperatingExpenses
1606000 USD
us-gaap Operating Expenses
OperatingExpenses
1104000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
111000 USD
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
10000 USD
us-gaap Other Operating Income
OtherOperatingIncome
44000 USD
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1000 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-70000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-90000 USD
CY2021Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-89000 USD
CY2020Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
25000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000 USD
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
50000 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
333000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-220000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
584000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
291000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-291000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
699000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-701000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-53000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1897000 USD
us-gaap Net Income Loss
NetIncomeLoss
-405000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58446000 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58110000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58377000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58119000 shares
us-gaap Net Income Loss
NetIncomeLoss
-1897000 USD
us-gaap Net Income Loss
NetIncomeLoss
-405000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19000 USD
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
30000 USD
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
29000 USD
sir Employee Stock Option Expense
EmployeeStockOptionExpense
104000 USD
sir Employee Stock Option Expense
EmployeeStockOptionExpense
287000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
50000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 USD
us-gaap Other Income
OtherIncome
-10000 USD
us-gaap Other Income
OtherIncome
-44000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-34000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-281000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
60000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-118000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1723000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-716000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1837000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
488000 USD
sir Purchase Of Mineral Property
PurchaseOfMineralProperty
-458000 USD
sir Purchase Of Mineral Property
PurchaseOfMineralProperty
0 USD
sir Purchase Of Other Assets Net
PurchaseOfOtherAssetsNet
-39000 USD
sir Purchase Of Other Assets Net
PurchaseOfOtherAssetsNet
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
104000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
123000 USD
sir Sale Purchase Of Derivative Instruments Net
SalePurchaseOfDerivativeInstrumentsNet
8000 USD
sir Sale Purchase Of Derivative Instruments Net
SalePurchaseOfDerivativeInstrumentsNet
-121000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1452000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
490000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
137000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
83000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
sir Proceed Paycheck Protection Loan
ProceedPaycheckProtectionLoan
0 USD
sir Proceed Paycheck Protection Loan
ProceedPaycheckProtectionLoan
70000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
220000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-51000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-161000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
605000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
574000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
413000 USD
sir Accrued Mineral Property Acquisition Costs Included In Accounts Payable
AccruedMineralPropertyAcquisitionCostsIncludedInAccountsPayable
60000 USD
sir Accrued Mineral Property Acquisition Costs Included In Accounts Payable
AccruedMineralPropertyAcquisitionCostsIncludedInAccountsPayable
0 USD
sir Acquisition Of Right To Use Asset
AcquisitionOfRightToUseAsset
99000 USD
sir Acquisition Of Right To Use Asset
AcquisitionOfRightToUseAsset
0 USD
sir Conversion Of Silverstream Note To Marketable Equity Securities
ConversionOfSilverstreamNoteToMarketableEquitySecurities
0 USD
sir Conversion Of Silverstream Note To Marketable Equity Securities
ConversionOfSilverstreamNoteToMarketableEquitySecurities
294000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
600000 USD
CY2021Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5513000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">Solitario faces risks related to health epidemics and other outbreaks of communicable diseases, which could significantly disrupt its operations and may materially and adversely affect its business and financial conditions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">Solitario’s business could be adversely impacted by the effects of the coronavirus (“COVID-19”) or other epidemics or pandemics. Solitario has recommended all of its employees and contractors follow government guidelines for health and safety policies for employees and contractors, including encouraging tele-commuting and working from home where possible. Solitario has evaluated the effects of the COVID-19 pandemic on its operations and since the outbreak of the pandemic has taken pro-active steps to address the impact on its operations, including reducing certain costs, in response to the economic uncertainty associated with potential risks from the COVID-19 pandemic. Solitario will continue to monitor the effects of the COVID-19 pandemic on its operations, financial condition and liquidity. However, the extent to which the COVID-19 pandemic ultimately impacts Solitario’s business, including our exploration and other activities and the market for our securities, will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of the outbreak and governmental actions taken to contain or treat the coronavirus outbreak. </p>
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
410000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3283000 USD
sir Maturities Period
MaturitiesPeriod
12
CY2021Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
250000 USD
CY2020Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
100000 USD
CY2021Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
601000 USD
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5698000 shares
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
75000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
65000 USD
CY2021Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
16129000 USD
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
15628000 USD
us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
3000000 USD
sir Total
Total
200000 USD
CY2021Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.020 pure
CY2021Q3 sir Reduce Return Royalty Rate
ReduceReturnRoyaltyRate
0.01 pure
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
1000000 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
393000 USD
sir Exploration Program
ExplorationProgram
622000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
294000 USD
us-gaap Royalty Expense
RoyaltyExpense
250000 USD
us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
350000 USD
CY2020Q2 sir Accured Interest Payable Rate
AccuredInterestPayableRate
0.08 pure
us-gaap Interest And Other Income
InterestAndOtherIncome
7000 USD
CY2021Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
413000 USD
CY2020Q3 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
91000 USD
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
751000 USD
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
204000 USD
CY2021Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
29000 USD
CY2020Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
21000 USD
CY2021Q3 sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
442000 USD
CY2020Q3 sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
112000 USD
sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
826000 USD
sir Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
269000 USD
CY2021Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
125000 USD
CY2021Q3 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-50000 USD
us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-220000 USD
CY2020Q3 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-333000 USD
us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-584000 USD
CY2021Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1226000 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1620000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
73000 USD
CY2021Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1925000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2099000 USD
CY2021Q3 sir Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-699000 USD
CY2020Q4 sir Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-479000 USD
CY2021Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1226000 USD
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1620000 USD
CY2021Q3 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
105000 USD
CY2020Q3 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
174000 USD
CY2021Q3 sir Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
-89000 USD
CY2020Q3 sir Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
25000 USD
sir Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
-70000 USD
sir Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
50000 USD
CY2021Q3 sir Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-16000 USD
CY2020Q3 sir Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-47000 USD
sir Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-104000 USD
sir Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-123000 USD
CY2021Q3 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-39000 USD
CY2020Q3 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
358000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-290000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
634000 USD
us-gaap Payments For Proceeds From Availableforsale Securities Shortterm
PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm
0 USD
CY2020Q3 us-gaap Payments For Proceeds From Availableforsale Securities Shortterm
PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm
0 USD
CY2021Q3 us-gaap Payments For Proceeds From Availableforsale Securities Shortterm
PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm
0 USD
us-gaap Payments For Proceeds From Availableforsale Securities Shortterm
PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm
294000 USD
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-55000 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
311000 USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
394000 USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
805000 USD
CY2021Q3 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
50000 USD
CY2020Q3 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
333000 USD
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
-220000 USD
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
584000 USD
sir Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
50000 USD
CY2021Q3 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-39000 USD
CY2020Q3 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
358000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-290000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
634000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9000 USD
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
11000 USD
CY2021Q3 sir Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
-89000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
28000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
10000 USD
sir Discount Rate
DiscountRate
0.05 pure
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
99000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
174000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
39000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
36000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
86000 USD
CY2021Q3 sir Less Amount Of Payments Representing Interest
LessAmountOfPaymentsRepresentingInterest
-4000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
82000 USD
CY2021Q3 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
10000 USD
CY2020Q3 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
10000 USD
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
27000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
124000 USD
CY2020Q2 sir Paycheck Protection Loan
PaycheckProtectionLoan
70000 USD
us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.01 pure
us-gaap Other Income Disclosure Nonoperating
OtherIncomeDisclosureNonoperating
10,000
sir Forgiveness Of The Ppp Loan
ForgivenessOfThePppLoan
-10000 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
3884000 USD
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
1226000 USD
CY2021Q3 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
7000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
5798000 USD
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
1620000 USD
CY2020Q4 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
49000 USD
sir Stock Option Expense
StockOptionExpense
104000 USD
sir Issuance Of Shares Atm Net Value
IssuanceOfSharesAtmNetValue
137000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
83000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1897000 USD
us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
125000 USD
CY2021Q3 us-gaap Prepaid Rent
PrepaidRent
86000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
22494000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
21929000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
24131000 USD
CY2013Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5750000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5513000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5558000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.25 pure
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
185000 shares
sir Exercise Price
ExercisePrice
0.45
sir Proceeds From Options Exercised
ProceedsFromOptionsExercised
83000 USD
CY2021Q3 sir Stock Option Compensation Expense
StockOptionCompensationExpense
32000 USD
sir Stock Option Compensation Expense
StockOptionCompensationExpense
104000 USD
CY2020Q3 sir Stock Option Compensation Expense
StockOptionCompensationExpense
72000 USD
sir Stock Option Compensation Expense
StockOptionCompensationExpense
287000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
100000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P22Y
CY2021Q3 sir Stock Option Expense
StockOptionExpense
32000 USD
CY2021Q3 sir Issuance Of Shares Atm Net Value
IssuanceOfSharesAtmNetValue
104000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-701000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
21929000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
23990000 USD
CY2020Q3 sir Stock Option Expense
StockOptionExpense
72000 USD
CY2020Q3 sir Purchase Of Shares For Cancellation Amount
PurchaseOfSharesForCancellationAmount
-1000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-53000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
24008000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23502000 USD
sir Stock Option Expense
StockOptionExpense
287000 USD
sir Purchase Of Shares For Cancellation Amount
PurchaseOfSharesForCancellationAmount
-5000 USD
us-gaap Net Income Loss
NetIncomeLoss
-405000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
24008000 USD
CY2021Q3 sir Shares Repurchased
SharesRepurchased
3600 shares
sir Shares Repurchased
SharesRepurchased
24700 shares
CY2021Q3 sir Aggregate Purchase Price
AggregatePurchasePrice
1000 USD
sir Aggregate Purchase Price
AggregatePurchasePrice
5000 USD
CY2021Q3 sir Total Shares Repurchased Shares
TotalSharesRepurchasedShares
994000 shares
CY2021Q3 sir Total Shares Repurchased
TotalSharesRepurchased
467000 USD

Files In Submission

Name View Source Status
0001654954-21-011834-index-headers.html Edgar Link pending
0001654954-21-011834-index.html Edgar Link pending
0001654954-21-011834.txt Edgar Link pending
0001654954-21-011834-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sir-20210930.xsd Edgar Link pending
sir-20210930_cal.xml Edgar Link unprocessable
sir-20210930_def.xml Edgar Link unprocessable
sir-20210930_lab.xml Edgar Link unprocessable
sir-20210930_pre.xml Edgar Link unprocessable
sir_10q.htm Edgar Link pending
sir_10q_htm.xml Edgar Link completed
sir_ex311.htm Edgar Link pending
sir_ex312.htm Edgar Link pending
sir_ex321.htm Edgar Link pending